Qms Medical Allied Services Ltd vs Syngene International Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of QMS Medical Allied Services Ltd is ₹ 172.21 as of 23 Oct 15:30 . The P/E Ratio of QMS Medical Allied Services Ltd changed from 23.2 on March 2024 to 13.7 on March 2026 . This represents a CAGR of -16.10% over 3 yearsThe P/E Ratio of Syngene International Ltd changed from 53.7 on March 2021 to 49.7 on March 2026 . This represents a CAGR of -1.28% over 6 years The Market Cap of QMS Medical Allied Services Ltd changed from ₹ 208.93 crore on March 2024 to ₹ 139.23 crore on March 2026 . This represents a CAGR of -12.65% over 3 yearsThe Market Cap of Syngene International Ltd changed from ₹ 21734 crore on March 2021 to ₹ 15724 crore on March 2026 . This represents a CAGR of -5.25% over 6 years The revenue of QMS Medical Allied Services Ltd for the Jun '26 is ₹ 57.28 crore as compare to the Mar '26 revenue of ₹ 44.65 crore. This represent the growth of 28.29% The revenue of Syngene International Ltd for the Jun '26 is ₹ 761.3 crore as compare to the Mar '26 revenue of ₹ 1058 crore. This represent the decline of -28.09% The ebitda of QMS Medical Allied Services Ltd for the Jun '26 is ₹ 8.73 crore as compare to the Mar '26 ebitda of ₹ 6.13 crore. This represent the growth of 42.41% The ebitda of Syngene International Ltd for the Jun '26 is ₹ 102.6 crore as compare to the Mar '26 ebitda of ₹ 319.6 crore. This represent the decline of -67.9% The net profit of QMS Medical Allied Services Ltd changed from ₹ 2.4 crore to ₹ 3.96 crore over 9 quarters. This represents a CAGR of 24.93% The net profit of Syngene International Ltd changed from ₹ 75.7 crore to ₹ -9 crore over 9 quarters. This represents a CAGR of NaN% The Dividend Payout of QMS Medical Allied Services Ltd changed from 9.92 % on March 2024 to 144.54 % on March 2026 . This represents a CAGR of 144.24% over 3 yearsThe Dividend Payout of Syngene International Ltd changed from 10.18 % on March 2022 to 16.52 % on March 2026 . This represents a CAGR of 10.17% over 5 years .

About QMS Medical Allied Services Ltd

QMS Medical Allied Services Limited was incorporated as 'QMS Medical Allied Services Private Limited' on September 14, 2017.
The status of the Company was changed to Public Limited and name of the Company changed to QMS Medical Allied Services Limited on October 22, 2020.
The Company is engaged in marketing, trading and distribution of a wide range of Medical Products, Medical and Surgical Instruments, Medical Equipments & Accessories and Medical Devices. Presently, the Company manage a wide range portfolio of products sold under brand 'Qdevices' and also distribution for other brands such as 3M, Heine, Rossmax etc.
Further, it organizes and provides medical education to members belonging to medical fraternity like, physicians, nurses, nurse practitioners, physician assistants, pharmacists, and other healthcare professionals by partnering with renowned medical education institutions such as EACME.

About Syngene International Ltd

Syngene International Limited is an integrated research, development and manufacturing services organization serving global pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical sectors.
Headquartered in India, the operations are driven by its highly qualified teams comprising 5641 scientists and its state-of-the-art facilities, spread over 2.5 million sq. ft., across 3 locations in India: Bangalore, Hyderabad and Mangalore.
The Company operate into 4 business divisions comprising of Discovery Services, Development Services, Manufacturing Services and the Dedicated Centers. Syngene International Limited was incorporated at Bangalore in 1993.
The Company was promoted by Biocon and Kiran Mazumdar Shaw, a promoter of Biocon Limited.
The Company's health-related services extend across all major therapeutic areas and modalities.

FAQs for the comparison of QMS Medical Allied Services Ltd and Syngene International Ltd

Which company has a larger market capitalization, QMS Medical Allied Services Ltd or Syngene International Ltd?

Market cap of QMS Medical Allied Services Ltd is 333 Cr while Market cap of Syngene International Ltd is 14,810 Cr

What are the key factors driving the stock performance of QMS Medical Allied Services Ltd and Syngene International Ltd?

The stock performance of QMS Medical Allied Services Ltd and Syngene International Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for QMS Medical Allied Services Ltd and Syngene International Ltd?

As of October 25, 2026, the QMS Medical Allied Services Ltd stock price is INR ₹172.21. On the other hand, Syngene International Ltd stock price is INR ₹366.9.

How do dividend payouts of QMS Medical Allied Services Ltd and Syngene International Ltd compare?

To compare the dividend payouts of QMS Medical Allied Services Ltd and Syngene International Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.